Partial knockdown of ACSL3 via doxycycline-inducible shRNA constructs impairs proliferation of NF2-KO cells in cell culture (Fig. 3D-E) and also significantly impairs the growth of NF2-KO schwannoma xenografts (Fig. 3F). The gene discussed is ACSL3; the disease is schwannoma.